| __timestamp | Amneal Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 49315000 |
| Thursday, January 1, 2015 | 109679000 | 75043000 |
| Friday, January 1, 2016 | 118757000 | 83749000 |
| Sunday, January 1, 2017 | 109046000 | 122682000 |
| Monday, January 1, 2018 | 230435000 | 207761000 |
| Tuesday, January 1, 2019 | 289598000 | 284812000 |
| Wednesday, January 1, 2020 | 326727000 | 317875000 |
| Friday, January 1, 2021 | 365504000 | 282660000 |
| Saturday, January 1, 2022 | 399700000 | 451421000 |
| Sunday, January 1, 2023 | 429675000 | 481871000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Sarepta's SG&A expenses surged by approximately 878%, peaking in 2023. Meanwhile, Amneal's costs increased by about 408%, reaching their highest in the same year. Notably, Sarepta's expenses surpassed Amneal's in 2022, marking a significant shift in their financial strategies. This trend highlights the dynamic nature of the industry, where companies must balance innovation with cost management. As these two companies continue to evolve, their SG&A expenses offer a window into their strategic priorities and market positioning.
Johnson & Johnson or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Sarepta Therapeutics, Inc.
GSK plc or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for argenx SE and Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Ascendis Pharma A/S
Sarepta Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
Alkermes plc or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.